Home > Insider Trading > Filing (0001562180-22-001784)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1770121	Sana Biotechnology Inc.	SANA	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1830054	J. James Macdonald	C/O Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 Seattle WA 98102	Evp & General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-15	1,000	$18.23	429,750	No	5	A	Direct
Common Stock	Disposition	2022-02-18	333	$6.28	429,417	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	A	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	7,812	Indirect	Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10
Common Stock	125,000	Indirect	Held by the KOM Trust
Common Stock	125,000	Indirect	Held by the NMM Trust

Footnotes

The reporting person is voluntarily reporting the acquisition of shares of common stock of Sana Biotechnology, Inc. (the "Issuer") pursuant to the Sana Biotechnology, Inc. 2021 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 3, 2021 through November 15, 2021. This transaction is exempt under Rule 16b-3(c).
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 15, 2021.
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.